MRNA | ||
---|---|---|
OUTLOOK RATING 1..100 | 53 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | |
PROFIT vs RISK RATING 1..100 | 87 | |
SMR RATING 1..100 | 96 | |
PRICE GROWTH RATING 1..100 | 65 | |
P/E GROWTH RATING 1..100 | 2 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
GLOF | MRNA | |
---|---|---|
RSI ODDS (%) | 1 day ago77% | 1 day ago71% |
Stochastic ODDS (%) | 1 day ago90% | 1 day ago80% |
Momentum ODDS (%) | 1 day ago77% | N/A |
MACD ODDS (%) | 1 day ago70% | N/A |
TrendWeek ODDS (%) | 1 day ago75% | 1 day ago80% |
TrendMonth ODDS (%) | 1 day ago75% | 1 day ago82% |
Advances ODDS (%) | 1 day ago84% | 1 day ago79% |
Declines ODDS (%) | 7 days ago71% | 6 days ago83% |
BollingerBands ODDS (%) | 1 day ago90% | N/A |
Aroon ODDS (%) | 1 day ago86% | 1 day ago79% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GGRCX | 14.82 | 0.11 | +0.75% |
Goldman Sachs Strategic Growth C | |||
MFVZX | 19.35 | N/A | N/A |
MassMutual Equity Opports I | |||
APLIX | 11.40 | -0.01 | -0.09% |
Cavanal Hill Hedged Income Investor | |||
FCCGX | 25.30 | -0.03 | -0.12% |
Fidelity Advisor Small Cap Growth C | |||
PHLCX | 18.78 | -0.04 | -0.21% |
PGIM Jennison Health Sciences C |
A.I.dvisor indicates that over the last year, GLOF has been loosely correlated with LLYVA. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if GLOF jumps, then LLYVA could also see price increases.
Ticker / NAME | Correlation To GLOF | 1D Price Change % | ||
---|---|---|---|---|
GLOF | 100% | +0.22% | ||
LLYVA - GLOF | 47% Loosely correlated | -0.16% | ||
VLTO - GLOF | 43% Loosely correlated | -0.49% | ||
MRNA - GLOF | 27% Poorly correlated | +0.80% | ||
ACA - GLOF | 26% Poorly correlated | -1.18% | ||
PCOR - GLOF | 25% Poorly correlated | +2.52% | ||
More |